AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player in the cancer-treatment industry. Its purchase of Medarex in July added a…